Mental Distress And Associated Factors in Kidney Transplant Recipients And Living Kidney Donors During COVID-19

Abstract

1. Background

The coronavirus disease 2019 (COVID-19) pandemic has caused significant psychological distress globally. Our study assessed the prevalence of psychological distress and associated factors during the COVID-19 pandemic among kidney transplant recipients and kidney donors.

2. Methods

A cross-sectional survey of 497 participants (325 recipients and 172 donors) was conducted from 1st May to 30th June 2020 in Singapore. The survey questionnaire assessed knowledge levels of COVID-19, socio-demographic data, health status, psychosocial impact of COVID-19, and precautionary behaviors during the pandemic. Psychological distress was defined as having anxiety, depression, or stress measured by the validated Depression, Anxiety, and Stress Scale-21. Linear regression analyses were used to assess factors associated with higher psychological distress.

3. Results

The prevalence of psychological distress was 14.3% (95% confidence interval: 11.5–17.6%) in the overall population; it was 12.8% (9.79–16.6%) in recipients and 13.4% (9.08–19.6%) in donors with no significant difference (P=0.67). Younger age (21–49 vs. ≥50 years), unmarried status, non-Singapore citizen, worse health conditions, and worrying about physical and mental health were associated with higher psychological distress. Malays (versus Chinese), taking precautionary measures (hand sanitization), and receiving enough information about COVID-19 were associated with lower psychological distress. No interactions were observed between recipients and donors.

4. Conclusions

At least one in ten recipients and donors suffer from psychological distress during the COVID-19 pandemic. Focused health education to younger adults, unmarried individuals, non-Singapore citizens, and those with poor health status could potentially prevent psychological distress in recipients and donors.

Keywords

COVID-19, Anxiety, Depression, Psychological distress, Kidney transplant.

Click here to know the Cistanche benefits for Kidney

Introduction

The Coronavirus disease (COVID-19) outbreak has resulted in significant public health burdens globally; over 150 million confirmed cases and two million deaths have been reported from 223 countries, areas, or territories as of 27 February 2021 [1]. Many countries have responded to the outbreak by adopting multi-faceted interventions including lockdowns, travel restrictions, social distancing, and protective measures (e.g., wearing masks) [2]. However, the disruptions in economic development, personal routines, and social interactions may have posed heavy psychological distress worldwide. Systematic reviews and meta-analyses of up to 68 studies from 19 countries found that around 30% of the general population and 55% of high-risk patients (e.g., cancer, type 2 diabetes, COVID-19) had symptoms of anxiety or depression during COVID-19 [3, 4]. By evaluating psychological distress and its associated factors, urgent interventions to mitigate its impact can be initiated during future pandemics.

Female gender, younger adults, lower socioeconomic status, longer media exposure, and individuals having pre-existing physical conditions have been identified by previous studies of the general population as risk factors for increased psychological distress [4]. Patients with chronic kidney disease (CKD), especially those who are on chronic immunosuppression following kidney transplant surgeries, are at particularly high risk of COVID-19 infection and mortality [5–7]. To the best of our knowledge, the prevalence of psychological distress and associated factors during the COVID-19 pandemic have not been explored among kidney transplant recipients and living kidney donors. This knowledge would be especially informative as a recent study showed that stress-related disorders increase the risk of CKD progression and acute kidney injury by 23% [8].

Therefore, we aimed to evaluate the prevalence of, and factors associated with psychological distress during the COVID-19 pandemic among kidney transplant recipients and living kidney donors and compare the differences between the two groups. We hypothesize that the prevalence of psychological distress during the COVID-19 pandemic is significantly higher among kidney transplant recipients compared to donors, and younger age and lack of knowledge regarding COVID-19 will be associated with higher odds of psychological distress.

Methods

1. Study design and study population

We performed a cross-sectional, hospital-based survey on kidney transplant recipients and donors who were on follow-up care with Singapore General Hospital (SGH). The kidney transplant program at SGH has the highest number of recipients and donors under its follow-up in Singapore. The survey was conducted between 1st May to 30th June 2020, which coincided with the legislative nationwide lockdown. Transplant coordinators (TCs) contacted all recipients (n=863) and donors (n=270) in the registry for enrollment. Since face-to-face consent was not allowed during the lockdown, verbal informed consent was obtained via a video call before administering the questionnaire. An information sheet and consent form were subsequently sent to consented participants.

Participants could choose between having a video or phone interview with TCs who had undergone training on administering the instrument or filling out a self-administered online questionnaire. Each participant filled out the survey once. Surveys were conducted in either English or Mandarin. All surveys were anonymous, and the confidentiality of the information was ensured. The study was approved by the Ethics Review Committee from the SingHealth Centralised Institutional Review Board (2020/2364). The analysis for the current study was approved by the Institutional Review Board, National University of Singapore (NUS-IRB-2020-160).

Cistanche supplements

2. Study outcomes and variables

The survey questionnaire was developed in English and translated into Mandarin. The questionnaire assessed (1) socio-demographic status, (2) health status, (3) impact of COVID-19, (4) coping strategies (5) knowledge levels, (6) precautionary measures, and (7) availability of health information during the pandemic.

The primary outcome was the psychological distress of COVID-19 in the preceding 4 weeks, which was assessed using the Depression, Anxiety, and Stress Scale −21 Items (DASS-21) – a validated questionnaire comprising three subscales for depression, anxiety, and stress. Cutoff scores of more than 9, 7, and 14 indicated the presence of depression, anxiety, and stress, respectively. The English version [9] and Chinese version [10] of the DASS-21 questionnaire have both been validated in studies evaluating psychological distress in Singapore and China [10–13]. Other components of the survey, as described below, were translated into Chinese by two independent study team members (HX, YW) who are proficient in the language.

Self-reported demographic characteristics included age (21–49, or> 50 years), gender, ethnicity (Chinese, Malay, Indian, or others), marital status (married or others), type of housing as a surrogate for socioeconomic status (government housing [HDB/HUDC], or others), employment status (employed, or unemployed), education levels (primary and lower, or secondary and higher), religion (Buddhist, Christian, or others), and residence status (Singaporean citizen or non-citizen). The vast majority of Singaporeans (78.7%) typically live in government housing (HDB/HUDC) [14] while 16.3% are likely more affluent and live in private housing. In Singapore, 74.3% are Chinese, 13.4% are Malays and 9.4% are Indians [15]; therefore, Indians and Malays were defined as ethnic minorities.

Participants were asked to rate their general health condition (poor or fair, or good, very good or excellent), indicate the frequency of hospital admissions and doctor consultations (never, or once or more), the presence of any general respiratory symptoms in the preceding 14days, and possible first action after getting sick (self-medicate or seek help from medical staff). For general health conditions, “poor or fair” was the reference group, and for the frequency of hospital admissions and doctor consultations, “never” served as the reference group.

Participants were asked about their worries about their health, the health of household members, finance, mental health, loneliness and isolation, quality of healthcare received, enough supply of food and medications, as well as their confidence in the Singapore government and healthcare system to control the spread of COVID-19. The response using a 4-item Likert scale (e.g., never, sometimes, most of the time, or always), was converted to a numerical score (e.g., never=0, sometimes=1, most of the time=2, and always =4) for further analysis.

Knowledge levels of COVID-19 were assessed by ten questions on infection, prevention, and treatment of COVID-19 (e.g., loss of taste and smell can be a possible sign of COVID-19, etc.). Response options of “true”, “false” and “do not know” were computed to form a knowledge score (true=“1”, false/do not know=“0”). The total score ranged from 0 to 10, with a higher score representing better knowledge of COVID-19.

Questions on precautionary measures assessed how often participants stay at home, or adopt hygiene measures (e.g., sanitizing hands, keeping a safe distance, wearing a mask, etc.). Responses were recorded using a 4-item Likert scale. Sources of COVID-19 information, frequency of updates, and whether they think the information they received from their healthcare providers was enough were used to assess the availability of health information.

3. Statistical analysis

The sample sizes were calculated using the eq. N=Zα2×P × (1−P) / d2 where α=0.05, Zα=1.96, and d=0.1. The prevalence of psychological distress was estimated at 20% [12, 13]. To ensure adequate power for analysis, we allowed a response rate as low as 40%; therefore, the calculated sample size for each group was 154, and the total sample size was 308.

Since the prevalence of psychological distress was low, we used linear regression analyses to assess associations between patients’ characteristics and psychological distress to capture more information. Model 1 was the univariate model, and Model 2 included socio-demographic variables. Model 3 consisted of all variables in Model 1, and Model 4 was the fully adjusted parsimonious model using the forward stepwise procedure to select variables with P<0.20 from Model 3. We further kept those variables with P<0.05 in the final model (Model 4). Interactions between patients’ characteristics and patient type (recipients or donors) were examined in interaction terms in Model 2 (for socio-demographic variables) and Model 3 (for the remaining factors). All statistical analyses were conducted using STATA version 14.0 (College Station, TX: StataCorp LP), where a two-sided P value <0.05 was considered statistically significant.

Herba Cistanche

Discussion

In the current study in Singapore, we found that at least one in ten kidney transplant recipients and donors suffered from psychological distress during the COVID-19 pandemic. In the overall population, younger age (21–49 vs. ≥ 50 years), unmarried status, non-Singapore citizenship, worse health conditions, and worrying about physical and mental health were associated with higher psychological distress. Malays (versus Chinese), taking precautionary measures (hand sanitization), and receiving enough information about COVID-19 were associated with lower psychological distress. The relationship between the determinants of psychological distress did not vary between the recipients and donors. Interventions such as targeted-health education including encouragement towards physical exercise, more frequent telehealth consults, and rapid access to mental health care or supportive online groups for younger adults, unmarried individuals, non-Singapore citizens, and those with worse health conditions could potentially reduce the risk of psychological distress in these vulnerable groups [16–19].

The prevalence of psychological distress among kidney donors who were largely healthy (13.4 [9.08–19.6%]), was much lower compared to the 30% among a predominantly general population reported from 68 studies in 19 countries during the COVID-19 pandemic [3, 4]. The lower prevalence of psychological distress in Singapore compared to the rest of the world was also observed in a prior study conducted among healthcare workers (7% [95% confidence interval: 5–9%] versus 26% [18–34%]) [3, 13]. Of note, Singapore also had one of the lowest numbers of COVID-19 cases (10,473 per million population as of 14 February 2021) and mortality (5 deaths per million population) [1] globally, which was likely due to efficient national responses and high-quality medical care. Specifically, since the start of the outbreak, the Singapore government had proactively established official COVID-19 resources and subscription services, as well as frequent briefings and press conferences by the Prime Minister and other officials, to keep the public informed of the latest COVID-19 situation in Singapore [20]. In addition, protective measures such as wearing masks and social distancing have been mandated by the law and strictly enforced in Singapore since April 2020 [21], while free masks and sanitizers were distributed across the country. Furthermore, easy access to free COVID-19 testing, robust contact tracing, and sufficient medical care capacities were instrumental in arresting the spread of COVID-19 and related mortality; various resources and schemes were also promptly established to target financial disruptions, and 24-h National Care hotlines and other online platforms were provided to alleviate the worries of the public [22–25]. In the current study, more than 90% of both recipients and donors showed confidence in the government and healthcare system of Singapore to control the spread of COVID-19, which suggests that the existing comprehensive interventions may have contributed to the low prevalence of psychological distress.

It is also interesting to observe a low prevalence of psychological distress among high-risk kidney transplant recipients in the current study (12.8% [9.79–16.6%]), which was substantially lower compared to the 55% among other high-risk patients (e.g. cancer, type 2 diabetes, COVID-19) [3], and the 39% (clinical anxiety or depression symptoms) among patients with end-stage kidney disease on hemodialysis [26]. In addition to the effective national responses, the low psychological distress among recipients could also be attributed to the high-quality medical care and intensive follow-ups by the SGH transplant program [27]. Since the COVID-19 outbreak, the SGH transplant program has adopted a multi-pronged approach to alleviating the impact of the pandemic including a rapid transition to video and tele-consults to minimize potential patient exposure to COVID-19, ensuring safe paths for patients who needed to come to the hospital, ensuring a stable supply chain of immunosuppression, and sustaining patient and staff education programs via video conferencing [27]. Specifically, two COVID-19 webinars (on May 9th, 2020, and May 30th, 2020) were held to improve the COVID-19 knowledge of recipients, in addition to the official social media platform for the kidney recipients which provided a portal for dissemination of electronic education material and peer-support [28, 29]. As a result of the intensive education, recipients had higher COVID-19 knowledge compared to donors and were more likely to adopt precautionary measures (e.g., hand sanitization), and report that they have received enough COVID-19 information from healthcare providers (79.3% versus 36.2%). Adopting precautionary measures and receiving enough information about COVID-19 were both independently associated with lower psychological distress in the current study, suggesting that the intensive intervention and health education at SGH could have contributed to the substantially lower prevalence of psychological distress among the high-risk kidney transplant recipients in the current study. Nevertheless, we noted that only 36.2% of the donor population thought that they have received enough information from healthcare providers. Programs in Singapore and elsewhere should proactively engage their kidney donors for health education, especially during a public health crisis.

Standardized Cistanche

In addition, the higher psychological distress during COVID-19 among non-Singapore citizens versus Singapore citizens could be partly attributed to outbreaks of COVID-19 occurring in dormitories of migrant workers in Singapore [30, 31]; the potentially higher expenses of medical care for non-Singapore citizens might have also contributed to the higher psychological distress. Thus, proactive health education, access to mental health counseling services, high-quality affordable medical care, and avenues to alleviate the economic impact of the pandemic must include this vulnerable population to reduce health inequities locally and globally [32–34]. It is also important to underscore that Malay ethnicity was independently associated with lower psychological distress compared to Chinese ethnicity. This was consistent with findings during non-COVID periods in Singapore [35], and might be explained by differences in religious beliefs, strengths of family ties, and social networks between the Malay and Chinese communities. Our results were in contrast to studies in Canada, the United Kingdom, and the United States where ethnic minorities had worse mental health [36, 37], and further studies are warranted to understand the unique protective factors of the Malay community in Singapore. Although the prevalence of psychological distress was relatively low among kidney recipients and donors, targeting younger adults, unmarried individuals, non-Singapore citizens, and those with worse health conditions could further improve psychological distress in high-risk kidney transplant recipients and kidney donors.

It is noteworthy that the current study was conducted before the availability of COVID-19 vaccines. As of 10 December 2021, 96% of Singapore’s eligible population (aged 12 years or older) has been fully vaccinated against COVID-19 [38]. Since the vaccines have significant potential to reduce COVID-19-associated morbidity and mortality among recipients and donors [39, 40] and to improve mental health distress [41, 42], the high vaccination rate in Singapore and subsequent boosters, as indicated, may have the potential to reduce the psychological distress among recipients and donors as observed in the current study. Further studies are warranted to validate our findings.

To the best of our knowledge, this is the first study assessing psychological distress and associated factors among kidney transplant recipients and donors. We approached all kidney recipients and donors in our registry for study enrollment, and our results could be generalized to countries with similarly low COVID-19 transmission rates. In addition, we used a validated instrument (DASS-21) in assessing psychological distress, thus ensuring the validity of our study outcomes.

However, our study had several limitations. First, potential selection bias may exist as we recruited patients from a single medical center. However, our center is the largest kidney transplant program in Singapore and provides medical care to the majority of kidney transplant recipients in Singapore. Second, we observed a low response rate for the current study (43.9% [41.3– 46.8%]), which may be due to the lack of face-to-face communication. However, a 40% response rate is not unusual for remotely administered anonymous surveys [43, 44]. Moreover, we accounted for a response rate of 40% in calculating the sample size, thus ensuring sufficient sample size and statistical power for the current analysis. Since all surveys were anonymous in the current study, we were not able to compare the characteristics of those who responded to our survey compared to those who did not. Third, the number of patients with psychological distress was relatively small; therefore, the power to demonstrate associations in multivariable-adjusted analyses may be limited. Fourth, the present study did not have information on graft function or immunosuppressive regimens, which may also impact the anxiety levels of transplant patients [45]. Fifth, the current study was a cross-sectional survey, and we could not adjust for baseline prevalence of psychological distress and mental health diagnoses; thus, the observed associations in the current study should be considered correlative not causative. Sixth, our results may not be generalizable to low-income settings where kidney recipients and donors may not receive sufficient medical care or countries with high COVID-19 transmission rates. In addition, some of the variables (e.g., having worries about physical or mental health, and feeling lonely and isolated) may not be entirely independent of symptoms of psychological distress; due to time constraints of the pandemic, we did not develop a pilot survey to standardize or validate all the questions in our study unlike the DASS-21 instrument and hence the results of those questions will require validation in other study populations. However, the primary outcome was based on the DASS-21 scale, which is validated for psychological distress and has been used previously in studies in Singapore [13].

Cistanche extract

In conclusion, we observed that at least one in ten kidney transplant recipients and donors suffered from psychological distress during the COVID-19 pandemic. Younger age, unmarried status, non-Singapore residence, worse health conditions, and worrying about physical and mental health were associated with higher psychological distress. Malays (versus Chinese), taking precautionary measures (hand sanitization), and receiving enough information about COVID-19 were associated with lower psychological distress. Focused health education targeting younger adults, unmarried individuals, non-Singapore citizens, and those with worse health conditions could potentially prevent psychological distress in high-risk kidney transplant recipients and the donor population.

References

1. World Health Organization. Coronavirus disease (COVID-19) pandemic.

2. Haug N, Geyrhofer L, Londei A, et al. Ranking the effectiveness of worldwide COVID-19 government interventions. Nat Hum Behav. 2020;4:1303–12.

3. Luo M, Guo L, Yu M, et al. The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and the general public – a systematic review and meta-analysis. Psychiatry Res. 2020;291:113190.

4. Wang Y, Kala MP, Jafar TH. Factors associated with psychological distress during the coronavirus disease 2019 (COVID-19) pandemic on the predominantly general population: a systematic review and meta-analysis. PLoS One. 2021;15:e0244630.

5. Akalin E, Azzi Y, Bartash R, et al. Covid-19 and kidney transplantation. N Engl J Med. 2020;382:2475–7.

6. Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–6.

7. Alberici F, Delbarba E, Manenti C, et al. A single-center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia. Kidney Int. 2020;97:1083–8.

8. Su G, Song H, Lanka V, et al. Stress-related disorders and the risk of kidney disease. Kidney Int Rep. 2021.

9. Lovibond SH, Lovibond PF. Manual for the depression anxiety stress scales, 2nd Ed. Sydney: Psychology Foundation of Australia; 1995.

10. Moussa MT, Lovibond P, Laube RE. Psychometric properties 1 Psychometric property of a Chinese version of the 21-item depression anxiety stress scales (DASS 21); 2016.

11. Yi W, Daxing W, Lu X, et al. Psychometric properties of the Chinese short version of depression anxiety and stress scale in Chinese adults. China Public Health. 2012;28:1436–8.

12. Chew NWS, Lee GKH, Tan BYQ, et al. A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak. Brain Behav Immun. 2020;88:559–65.

13. Tan BYQ, Chew NWS, Lee GKH, et al. The psychological impact of the COVID-19 pandemic on health Care Workers in Singapore. Ann Intern Med. 2020;173:317–20.

14. Department of Statistics Singapore. Population trends.

15. Department of Statistics Singapore. Population trends.

16. Aziz F, Jorgenson MR, Garg N, Mohamed M, Djamali A, Mandelbrot D, et al. The care of kidney transplant recipients during a global pandemic: challenges and strategies for success. Transplant Rev. 2020;34:100567.

17. Hossain MM, Tasnim S, Sultana A, Faizah F, Mazumder H, Zou L, et al. Epidemiology of mental health problems in COVID-19: a review. F1000Res. 2020;9:636.

18. Flannery H, Portnoy S, Daniildi X, Kambakara Gedara C, Korchak G, Lambert D, et al. Keeping young people connected during COVID-19: the role of online groups. Arch Dis Child. 2021.

19. Pascoe MC, Parker AG. Physical activity and exercise as universal depression prevention in young people: a narrative review. Early Interv Psychiatry. 2019;13:733–9.

20. gov.sg (2020) COVID-19 Resources.

21. Ministry of Health Singapore. COVID-19 (TEMPORARY MEASURES) ACT 2020 (ACT 14 OF 2020).

22. Lin RJ, Lee TH, Lye DC. From SARS to COVID-19: the Singapore journey. Med J Aust. 2020;212:497–502.

23. Ting DSW, Carin L, Dzau V, et al. Digital technology and COVID-19. Nat Med. 2020;26:459–61.

24. Sim HS, How CH. Mental health and psychosocial support during healthcare emergencies - COVID-19 pandemic. Singap Med J. 2020;61:357–62.

25. Ho CS, Chee CY, Ho RC. Mental health strategies to combat the psychological impact of COVID-19 beyond paranoia and panic. Ann Acad Med Singap. 2020;49:155–60.

26. Lee J, Steel J, Roumelioti M-E, et al. Psychosocial impact of COVID-19 pandemic on patients with end-stage kidney disease on hemodialysis. Kidney. 2020;360:1390–7.

27. Kee T, Hl VG, Shimin JC, et al. Managing a renal transplant Programme during the COVID-19 pandemic: practical experience from a Singapore transplant Centre. Ann Acad Med Singap. 2020;49:652–60.

28. A New Sprout of Life.

29. Chung SJ, Tan EK, Kee T, et al. Practical considerations for solid organ transplantation during the COVID-19 global outbreak: the experience from Singapore. Transplantation. Direct. 2020;6:e554.

30. Koh D. Migrant workers and COVID-19. Occup Environ Med. 2020;77:634–6. 31. Ngiam JN, Chew N, Tham SM, et al. The demographic shift in COVID-19 patients in Singapore from an aged, at-risk population to young migrant workers with reduced risk of severe disease. Int J Infect Dis. 2021;103:329–35. 32. Goh OQ, Islam AM, Lim JCW, et al. Towards health market systems changes for migrant workers based on the COVID-19 experience in Singapore. BMJ Glob Health. 2020;5:e003054.

33. Gottlieb N, Trummer U, Davidovitch N, et al. Economic arguments in migrant health policymaking: proposing a research agenda. Glob Health. 2020;16:113.

34. Brandenberger J, Baauw A, Kruse A, et al. The global COVID-19 response must include refugees and migrants. Swiss Med Wkly. 2020;150:w20263.

35. Vaingankar JA, Subramaniam M, Tan LWL, et al. Psychometric properties and population norms of the positive mental health instrument in a representative multi-ethnic Asian population. BMC Med Res Methodol. 2018;18:29.

36. Smith K, Bhui K, Cipriani A. COVID-19, mental health and ethnic minorities. Evid Based Ment Health. 2020;23:89–90.

37. Miconi D, Li ZY, Frounfelker RL, et al. Ethno-cultural disparities in mental health during the COVID-19 pandemic: a cross-sectional study on the impact of exposure to the virus and COVID-19-related discrimination and stigma on mental health across ethnocultural groups in Quebec (Canada). BJPsych Open. 2020;7:e14.

38. Singapore Ministry of Health. COVID-19 VACCINATION.

39. Haghpanah F, Lin G, Levin SA, Klein E. Analysis of the potential impact of durability, timing, and transmission-blocking of COVID-19 vaccine on morbidity and mortality. EClinicalMedicine. 2021;35.

40. Heldman MR, Limaye AP. SARS-CoV-2 vaccines in kidney transplant recipients: will they be safe and effective and How will we know? Clin J Am Soc Nephrol. 2021;32:1021–4.

41. Perez-Arce F, Angrisani M, Bennett D, et al. COVID-19 vaccines and mental distress. PLoS One. 2021;16:e0256406.

42. Koltai J, Raifman J, Bor J, et al. Does COVID-19 vaccination improve mental health? A difference-in-difference analysis of the understanding coronavirus in America study. medRxiv. 2021.

43. Agüero F, Adell MN, Pérez Giménez A, et al. Adoption of preventive measures during and after the 2009 influenza (H1N1) virus pandemic peak in Spain. Prev Med. 2011;53:203–6.

44. Krueger AB, Stone AA. Assessment of pain: a community-based diary survey in the USA. Lancet. 2008;371:1519–25.

45. Habwe VQ. Posttransplantation quality of life: more than graft function. Am J Kidney Dis. 2006;47:S98–S110.

Sobhana Thangaraju1,2, Yeli Wang 3, Terence Kee 1,2, Ping Sing Tee 1,2, York Moi Lu 1,2, Jing Hua Yong 1,2, Quan Yao Ho 1,2, Ian Tatt Liew1,2, Fiona Foo 1,2, Natelie Kwan 1,2, Eleanor Ng 1,2, Xia He 1,2, Constance Lee 1,2, Shannon Baey 1,2, Jenny Leong 1,2, Judy Tan 1,2, Rupesh Madhukar Shirore 3 and Tazeen Hasan Jafar 1,2,3,4.

1. Department of Renal Medicine, Singapore General Hospital, Singapore, Singapore.

2. SingHealth Duke-NUS Transplant Centre, Singapore, Singapore.

3. Program in Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.

4. Duke Global Health Institute, Duke University, Durham, NC, USA.